Cytogen, Inc. 217330

Cytogen, Inc., a biotechnology company, engages in blood cancer cell-based Liquid Biopsy application business in South Korea. The company offers cell isolators that enrich CTCs from human blood and/or body fluid using high density microporous chips; IF stainers, automated immunofluorescent staining system; and cell image analyzers, which help captures immunofluorescent images of cells stained with anti-EpCAM, -CD45, and CK antibodies. The company sells its products under the Smart Biopsy brand name. Cytogen, Inc. was founded in 2010 and is headquartered in Seoul, South Korea.

CEO

Mr. Byung-Hee Jeon

Employees

56

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

SeoulSouth Korea

High Today

$3,665.00

Low Today

$3,555.00

Open Today

$3,635.00

Volume Today

13,231.0

52 Week High

$13,200.00

52 Week Low

$2,920.00

Average Volume

67,714